It is expected that all StRs will have completed the full Stage 2 curricular requirements as per the 2020 curriculum, without any disruptions since their last ARCP. Progression to Stage 3 is expected to follow standard (pre-pandemic) ARCP requirements, without recourse to no-fault COVID outcomes in the majority of StRs. For those who have been unable to complete satisfactory capabilities or attachments due to COVID-19, irrespective of FFICM exam success, then additional time in stage 2 is likely to be necessary, with a no-fault 10.2.
Only in exceptional circumstances will progression to Stage 3 not be dependent on examination success, (though completion of Stage 3 and recommendation for a CCT will require passing the FFICM examination) when an Outcome 10.1 will be applied.
The Faculty propose the below guidance for ARCP Panels
Progression in the partner specialty will be determined by the relevant Colleges’ derogation guidance. Where re-deployment has occurred to support surge ICU capacity, the time in GICM could be considered towards Stage 3 training where the StR is considered ready for Stage 3. Stage 3 programme time could be re-adjusted to make up the partner specialty missing time and capabilities where needed.
We note that the emergency, respiratory, renal and acute medical specialties all have 6 months training time following the Stage 3 year during which missing capabilities could also be made up.
It appears that the anaesthetic dual specialty trainees are most likely to be affected by re-deployment, though it should be recognised and encouraged, via communications with relevant STCs, that transferable capabilities can be gained and acknowledged
Single ICM CCT StRs undertaking Special Skills Year should have been able to meet the expected curriculum capabilities.
